CARL ZEISS MEDITEC ADR 1 (AFXA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CARL ZEISS MEDITEC ADR 1 (AFXA) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€144.16 Million ≈ $168.54 Million USD) by net assets (€2.13 Billion ≈ $2.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of CARL ZEISS MEDITEC ADR 1 to measure how many days the company can operate on defensive assets alone.
CARL ZEISS MEDITEC ADR 1 - Cash Flow Conversion Efficiency Trend (2022–2025)
This chart illustrates how CARL ZEISS MEDITEC ADR 1's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CARL ZEISS MEDITEC ADR 1 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CARL ZEISS MEDITEC ADR 1 ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CENTRAL PUERTO ADR/1 AP1
F:C3TA
|
0.074x |
|
VIVENDI UNSPON.ARD EO 55
F:VVUD
|
N/A |
|
Odfjell Drilling Ltd
OL:ODL
|
0.081x |
|
Pertamina Geothermal Energy
JK:PGEO
|
0.026x |
|
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
|
0.009x |
|
Korea Circuit Co. Ltd.
KO:007810
|
-0.013x |
|
Shenzhen Overseas Chinese Town Co Ltd
SHE:000069
|
0.045x |
|
Payoneer Global Inc
NASDAQ:PAYO
|
0.079x |
Annual Cash Flow Conversion Efficiency for CARL ZEISS MEDITEC ADR 1 (2022–2025)
The table below shows the annual cash flow conversion efficiency of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see CARL ZEISS MEDITEC ADR 1 market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | €2.13 Billion ≈ $2.49 Billion |
€209.86 Million ≈ $245.35 Million |
0.099x | -17.99% |
| 2024-09-30 | €2.06 Billion ≈ $2.40 Billion |
€247.32 Million ≈ $289.14 Million |
0.120x | +4.17% |
| 2023-09-30 | €2.17 Billion ≈ $2.54 Billion |
€250.86 Million ≈ $293.28 Million |
0.115x | +24.53% |
| 2022-09-30 | €2.03 Billion ≈ $2.37 Billion |
€188.20 Million ≈ $220.02 Million |
0.093x | -- |
About CARL ZEISS MEDITEC ADR 1
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more